FDA Drug Recalls

Recalls / Firms / PACIRA PHARMACEUTICALS INC

PACIRA PHARMACEUTICALS INC

4 FDA drug recalls on record.

DateClassDrugStatus
2024-06-12Class IIZilrettaOngoing
2024-05-07Class IIZilrettaOngoing
2019-11-21Class IIExparelTerminated
2012-12-17Class IIEXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) sinTerminated